A clinical-stage biotechnology company focused on developing immuno-oncology therapies, including checkpoint antibodies, cancer vaccines, and immune adjuvants. Its pipeline targets multiple tumor types, with programs spanning early research through late-stage clinical trials and partnerships with la...
No congressional trades have been disclosed for Agenus Inc (AGEN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.